Abstract
Trials on the effect of systemic chemotherapy on survival and recurrence in adults with high-grade glioma have had inconclusive results. We undertook a systematic review and meta-analysis to assess the effects of such treatment on survival and recurrence. We did a systematic review and meta-analysis using updated data on individual patients from all available randomised trials that compared radiotherapy alone with radiotherapy plus chemotherapy. Data for 3004 patients from 12 randomised controlled trials were included (11 published and one unpublished). Overall, the results showed significant prolongation of survival associated with chemotherapy, with a hazard ratio of 0.85 (95% CI 0.78-0.91, p<0.0001) or a 15% relative decrease in the risk of death. This effect is equivalent to an absolute increase in 1-year survival of 6% (95% CI 3-9) from 40% to 46% and a 2-month increase in median survival time (1-3). There was no evidence that the effect of chemotherapy differed in any group of patients defined by age, sex, histology, performance status, or extent of resection. This small but clear improvement in survival from chemotherapy encourages further study of drug treatment of these tumours.
Keywords
MedicineMeta-analysisChemotherapyHazard ratioInternal medicineRadiation therapyRandomized controlled trialGliomaSurvival analysisProportional hazards modelOncologyClinical trialSurgeryConfidence interval
MeSH Terms
AdultCombined Modality TherapyFemaleGliomaHumansMaleMiddle AgedNervous System NeoplasmsRandomized Controlled Trials as TopicSurvival Rate
Affiliated Institutions
Related Publications
Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis
Objectives: Corticosteroids may be beneficial in sepsis, but uncertainty remains over their effects in severe influenza. This systematic review updates the current evidence rega...
National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
The panel concludes that decisions regarding adjuvant hormonal therapy should be based on the presence of hormone receptor protein in tumor tissues. Adjuvant hormonal therapy sh...
Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke
Background and Purpose Drug treatment of high blood pressure has been shown to reduce the associated cardiovascular risk. Stroke represents the type of event more strongly linke...
Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia
Background A recent review suggested an association between using unpublished scales in clinical trials and finding significant results. Aims To determine whether such an associ...
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint i...
Publication Info
- Year
- 2002
- Type
- review
- Volume
- 359
- Issue
- 9311
- Pages
- 1011-1018
- Citations
- 1221
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1221
OpenAlex
22
Influential
969
CrossRef
Cite This
Lesley Stewart
(2002).
Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.
The Lancet
, 359
(9311)
, 1011-1018.
https://doi.org/10.1016/s0140-6736(02)08091-1
Identifiers
- DOI
- 10.1016/s0140-6736(02)08091-1
- PMID
- 11937180